CytoCure

United States
Beverly, Massachusetts, United States
1-978-232-1243 ★

Company profile

CytoCure company profile

CytoCure LLC is an early-stage biopharmaceutical company founded on a novel platform technology to develop anti-cancer drugs that will make therapeutic cancer vaccines more effective. When combined with cancer immunotherapy, CytoCure's drugs will enhance patients' ability to recognize and destroy their own malignant tumors. CytoCure scientists have discovered a process by which tumor cells lose expression of genes encoding immune targets. This process of "antigen silencing" is a common finding among tumors. CytoCure scientists have shown that the loss of these antigens is often due to reversible gene regulation. Proprietary CytoCure technology is based on overcoming tumor-produced factors that induce..... For more information, log in to dureach.com to view the full company profile.

Business identity

Contact email
[email protected]
Phone number
1-978-232-1243
Operating status
Active
Company type
For Profit
Employee range
00011-00050 employees
Revenue range
$1K+
Founded
1999-01-01

Headquarters

Headquarters
Beverly, Massachusetts, United States
Postal code
01915
Country code
US
Continent
North America

Capital profile

Funding and company signals

No public funding data is available for this company.

Founders and investors

No public relation records are available.

People at this company

Preview only. Contact details are available after you sign in.

Log in to view people and contact details at this company

Contact information and company affiliations may no longer be accurate. Verify details before reaching out.

Shipment data

Explore detailed shipment data

Sign in to view shipment history, products, suppliers, and trade lanes for this company.

Log in to view shipment data

Shipment records and coverage can change as the dataset is updated.